Related references
Note: Only part of the references are listed.Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor
Masaaki Iwata et al.
BIOLOGICAL PSYCHIATRY (2016)
Pharmacometabolomics informs pharmacogenomics
Drew Neavin et al.
METABOLOMICS (2016)
TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
M. Gupta et al.
MOLECULAR PSYCHIATRY (2016)
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
G. B. Rogers et al.
MOLECULAR PSYCHIATRY (2016)
Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot Analysis
Daiki Setoyama et al.
PLOS ONE (2016)
Gut microbiota, metabolites and host immunity
Michelle G. Rooks et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
J. M. Biernacka et al.
TRANSLATIONAL PSYCHIATRY (2015)
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations
Yuan Ji et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Skeletal Muscle PGC-1α1 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression
Leandro Z. Agudelo et al.
CELL (2014)
Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
R. Kaddurah-Daouk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Treatment Outcomes of Depression The Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study
David A. Mrazek et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression
C. Lavebratt et al.
MOLECULAR PSYCHIATRY (2014)
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
Alban Bessede et al.
NATURE (2014)
Genetic variability in the regulation of gene expression in ten regions of the human brain
Adaikalavan Ramasamy et al.
NATURE NEUROSCIENCE (2014)
Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects A Systematic Review and Meta-analysis of Randomized Clinical Trials
Ole Kohler et al.
JAMA PSYCHIATRY (2014)
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Iain A. Murray et al.
NATURE REVIEWS CANCER (2014)
Contribution of Common Genetic Variants to Antidepressant Response
Katherine E. Tansey et al.
BIOLOGICAL PSYCHIATRY (2013)
Antimicrobial peptides and gut microbiota in homeostasis and pathology
Maureen J. Ostaff et al.
EMBO MOLECULAR MEDICINE (2013)
A mega-analysis of genome-wide association studies for major depressive disorder
Patrick F. Sullivan et al.
MOLECULAR PSYCHIATRY (2013)
Rapid antidepressant effects: moving right along
K. Martinowich et al.
MOLECULAR PSYCHIATRY (2013)
Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder - Possible Role for Methoxyindole Pathway
Hongjie Zhu et al.
PLOS ONE (2013)
Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics
Y. Ji et al.
PHARMACOGENOMICS JOURNAL (2013)
Gut-brain: how the microbiome influences anxiety and depression
Jane A. Foster et al.
TRENDS IN NEUROSCIENCES (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned
N. R. Wray et al.
MOLECULAR PSYCHIATRY (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
Ikwunga Wonodi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Daniel Zwilling et al.
CELL (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1
Bjoern O. Schroeder et al.
NATURE (2011)
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
R. Kaddurah-Daouk et al.
TRANSLATIONAL PSYCHIATRY (2011)
Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Holly A. Garriock et al.
BIOLOGICAL PSYCHIATRY (2010)
Radiation pharmacogenomics: A genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines
Nifang Niu et al.
GENOME RESEARCH (2010)
Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens
Sung-Hoon Lee et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
C. L. Raison et al.
MOLECULAR PSYCHIATRY (2010)
Gut Microbiota in Health and Disease
Inna Sekirov et al.
PHYSIOLOGICAL REVIEWS (2010)
The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages
Marc Daigneault et al.
PLOS ONE (2010)
Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism
Nam Trung Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression
Marcus Ising et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
Langerhans Cell Maturation and Contact Hypersensitivity Are Impaired in Aryl Hydrocarbon Receptor-Null Mice
Bettina Jux et al.
JOURNAL OF IMMUNOLOGY (2009)
Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guerin
Jason C. O'Connor et al.
JOURNAL OF NEUROSCIENCE (2009)
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo
P. F. Sullivan et al.
MOLECULAR PSYCHIATRY (2009)
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
J. C. O'Connor et al.
MOLECULAR PSYCHIATRY (2009)
Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple β-defensins in gingival keratinocytes
Andrea A Kalus et al.
BMC Oral Health (2009)
Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase
Christoph F. A. Vogel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The molecular neurobiology of depression
Vaishnav Krishnan et al.
NATURE (2008)
Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease
Agnes Katalin Kocsis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
The immune-mediated alteration of serotonin and glutamate:: towards an integrated view of depression
N. Mueller et al.
MOLECULAR PSYCHIATRY (2007)
Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population
Q-X Chen et al.
GENES AND IMMUNITY (2007)
Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor
Virginie Cerec et al.
HEPATOLOGY (2007)
Kynurenine pathway in major depression:: Evidence of impaired neuroprotection
Aye-Mu Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis
Yang Zhang et al.
BIOCHEMISTRY (2007)
Optimized THP-1 differentiation is required for the detection of responses to weak stimuli
E. K. Park et al.
INFLAMMATION RESEARCH (2007)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications
S Alesci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Increase in interleukin-1 beta in late-life depression
AJ Thomas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Defensins: Antimicrobial peptides of innate immunity
T Ganz
NATURE REVIEWS IMMUNOLOGY (2003)
Single-nucleotide Polymorphisms (SNPs) in human beta-defensin 1: High-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls
RJ Jurevic et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Share Paper
